945033-87-4

Upstream product

• 945033-85-2 6-N-t-butoxycarbonyl-8-(O-benzyl-N,N-bis[t-butoxycarbonyl]-DL-2''-propargylglycin-5''-yl)-2',3'-O-isopropylideneadenosine 
• 945033-81-8 6-N-t-butoxycarbonyl-8-iodo-2',3'-O-isopropylideneadenosine 
• 945033-80-7 6-N-t-butoxycarbonyl-5'-O-t-butyldimethylsilyl-8-iodo-2',3'-O-isopropylideneadenosine 
• 913823-87-7 tert-butyl (9-((3aR,4R,6R,6aR)-6-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-9H-purin-6-yl)carbamate 

Downstream Products

• 945033-89-6 6-N-t-butoxycarbonyl-8-(O-benzyl-N-t-butoxycarbonyl-DL-2''-propargylglycin-5''-yl)-2',3'-O-isopropylidene-5'-O-sulfamoyladenosine 

Relevant academic research and scientific papers

Exploiting ligand conformation in selective inhibition of non-ribosomal peptide synthetase amino acid adenylation with designed macrocyclic small molecules

Macrocyclic aminoacyl-AMP analogs have been developed to inhibit non-ribosomal peptide synthetase amino acid adenylation domains selectively by mimicking a cisoid ligand binding conformation observed in crystal structures. In contrast, these macrocycles d